1 year return (CAGR)
-92.08%
MyMD Pharmaceuticals Inc Exchange (NASDAQ, USD)
MYMD
-
+0.02 (+1.46%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-82.03%
5 year return (CAGR)
-71.56%
10 year return (CAGR)
-65.03%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
3.15M
Price/Sales
-
Ent value
28.62M
Price/Book
8.25
Div yield
-
Growth years
-
Div growth
-
FCF payout
-11.70%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-67.47%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 1.31 |
| Daily high | 1.36 |
| Daily low | 1.23 |
| Daily Volume | 23K |
| 1y analyst estimate | - |
| Beta | 2.69 |
| EPS (TTM) | -7.46 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| MYMD | S&P500 | |
| Current price drop from All-time high | -100.00% | -0.48% |
| Highest price drop | -100.00% | -56.47% |
| Date of highest drop | 18 Sep 2024 | 9 Mar 2009 |
| Avg drop from high | -98.29% | -10.68% |
| Avg time to new high | 676 days | 12 days |
| Max time to new high | 2701 days | 1805 days |
News
No items found